Top 5 Malaria treatment startups

Updated: May 09, 2024 | Editor: Jason Kwon

Malaria treatment startups are dedicated to combating this devastating disease by developing innovative technologies such as next-generation antimalarial drugs, point-of-care diagnostic tools, and mosquito control solutions. These startups aim to revolutionize malaria management by improving treatment efficacy, enabling early and accurate diagnosis, and implementing effective preventive measures, ultimately contributing to the global efforts to eradicate malaria and save countless lives in malaria-endemic regions.
1
Country: Israel | Funding: $123.8M
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
2
Country: USA | Funding: $100M
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization dedicated to accelerating the product development timeline for diseases that disproportionately affect the world’s poorest populations, starting with malaria, tuberculosis, and diarrheal diseases—diseases that combined cause five deaths every minute.*
3
Country: Netherlands | Funding: $17.1M
Landcent is accelerating the fight against infectious diseases of poverty through affordable, scalable and safe technologies.
4
Country: India
Meda Biotech is a clinical-stage biopharmaceutical company developing a new class of Hybrid- Nanoengineering water soluble drugs with unprecedented control over drug properties to maximize trafficking to disease sites, dramatically enhancing efficacy while minimizing toxicities.
5
Country: Australia
Vaxine is focused on development of innovative vaccine technologies. Vaxine’s human candidates include vaccines against seasonal and pandemic influenza, hepatitis B, Japanese encephalitis, West Nile Virus, malaria, rabies, and allergy.
Editor: Jason Kwon
Jason Kwon is a senior editor for MedicalStartups. He has previously covered the pharmaceutical and medical research industries for FDAnews and worked as a head of marketing for medical startup Sonic Therapeutics. Before that, he co-founded a startup consulting business for emerging entrepreneurial hubs in Asia. Jason graduated from St. Bonaventure University’s journalism school. In his free time, Jason enjoys yoga, watching movie trailers, traveling to places where he can't get cell service. You can contact Jason at jaskwon(at)medicalstartups(dot)com